Literature DB >> 25759650

Merkel Cell Carcinoma Concomitant with Invasive Bowen's Disease: Immunohistochemical Investigation of Tumor-Infiltrating Leukocytes.

Hisayuki Tono1, Taku Fujimura1, Eimei Iwama1, Yoshiyuki Kusakari1, Sadanori Furudate1, Yumi Kambayashi1, Takahiro Haga1, Akira Hashimoto1, Setsuya Aiba1.   

Abstract

Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma and, in rare cases, occurs with Bowen's disease (BD). In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of tumor-infiltrating leukocytes in the lesional skin of MCC and invasive BD. Interestingly, immunohistochemical study revealed significant numbers of CD8+ cells and caspase 3-expressing cells in the same areas of invasive BD and MCC. Our present case suggests that MCC concurrent with invasive BD might have a good prognosis because of the substantial number of CD8+ cells in the tumor.

Entities:  

Keywords:  CD8; Caspase 3; Invasive Bowen's disease; Merkel cell carcinoma; Tumor-infiltrating leukocytes

Year:  2015        PMID: 25759650      PMCID: PMC4327548          DOI: 10.1159/000371732

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Merkel cell carcinoma (MCC) is an aggressive, cutaneous, neuroendocrine carcinoma that originates from either Merkel cells or from pluripotent stem cells in the basal layer of the epidermis [1, 2]. Recent reports suggested that the type of tumor-infiltrating leukocytes (TILs) could determine the prognosis and tumor-specific survival of MCC [3, 4, 5]. Bowen's disease (BD) is defined as carcinoma in situ; the tumor shows atypical pleomorphism, cell clumping, irregular mitosis and individual cell keratinization. BD progresses to invasive BD, with the cytological characteristics of BD [6]. In addition, as we previously reported, both invasive and non-invasive BD contain substantial numbers of TILs, including CD8+ cells, Foxp3+ regulatory T cells (Tregs) and CD163+ macrophages [7]. Although several cases of MCC concurrent with BD have already been reported [8, 9], there has been no English language report investigating TILs in MCC with BD. In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of TILs in the lesional skin of MCC and invasive BD.

Case Report

A 71-year-old Japanese male visited our outpatient clinic with a 6-month history of a rapidly growing red plaque on his back. On his initial visit, physical examination revealed a red, pigmented plaque, 90 × 80 mm, with a dome-shaped elastic-soft nodule (fig. 1a). The diameter of the nodule was approximately 20 mm. A skin biopsy from the edge of the plaque revealed atypical squamous cells containing large oval nuclei with occasional conspicuous nucleoli, with individual keratinization, mitotic figures and clumping cells. In addition, the biopsy specimen from the center of the nodule revealed dense infiltrating atypical squamous cells throughout the dermis (fig. 1c). We first diagnosed this patient as invasive BD and excised the tumor with a 5-mm margin. Unexpectedly the histological finding of the whole tumor revealed that the squamous cell-composed tumor was surrounded by another type of tumor composed of small round cells with scant cytoplasm and oval nuclei (fig. 1b, d). These small round cells were positive for AE1/AE3, cytokeratin 20, synaptophysin and CD56, and negative for 34βE12, cytokeratin 7, chromogranin A and TTF1. From the above findings, we diagnosed this tumor as MCC concomitant with invasive BD. We screened for a possible internal malignancy with positron emission tomography computed tomography and found no evidence of metastasis.
Fig. 1

a Red, pigmented plaque on the back, 90 × 80 mm, with a dome-shaped elastic-soft nodule. b The squamous cell-composed tumor was surrounded by another type of tumor. c Center of the tumor (squamous cell-composing tumor area): the atypical squamous cells contained large oval nuclei and occasionally conspicuous nucleoli, with individual keratinization, mitotic figures and clumping cells. d Peripheral areas of the tumor: small round cells with scant cytoplasm and oval nuclei. Original magnification: b ×50; c, d ×200.

As we and other reports suggested [3, 4, 7], both invasive BD and MCC contain substantial numbers of immunoreactive and immunosuppressive cells. Notably, a previous report even suggested that the number of tumor-infiltrating CD8+ cells determines the prognosis of MCC [3]. Therefore, we further employed immunohistochemical staining for CD8 (fig. 2a, b), caspase 3 (fig. 2c, d), Foxp3 (fig. 3a, b), CD163 (fig. 3c, d) and CD206 (fig. 3e, f) in the lesional areas of invasive BD and MCC. Substantial numbers of immunoreactive and immunosuppressive cells were detected at the edge of the tumor in invasive BD, whereas TILs were scattered at the center of the tumor in MCC. Both invasive BD and MCC contained caspase 3-expressing cells in the CD8-infiltrated areas, which suggested induction of an anti-tumor immune response in the tumor microenvironment by CD8+ cytotoxic T cells.
Fig. 2

CD8+ cells and caspase 3+ cells in the areas of invasive BD and MCC. Paraffin-embedded tissue samples were deparaffinized and stained with anti-CD8 antibody (a, b) and anti-caspase 3 antibody (c, d) for the areas of invasive BD (a, c) and MCC (b, d). The sections were developed with liquid permanent red. Original magnification: ×200.

Fig. 3

Foxp3+ Tregs, CD163+ macrophages and CD206+ cells in the areas of invasive BD and MCC. Paraffin-embedded tissue samples were deparaffinized and stained with anti-Foxp3 antibody (a, b), anti-CD163 antibody (c, d) and anti-CD206 antibody (e, f) for the areas of invasive BD (a, c, e) and MCC (b, d, f). The sections were developed with liquid permanent red. Original magnification: ×200.

Discussion

Previous reports suggested the importance of evaluating the tumor microenvironment in the lesional skin of MCC. Indeed, Paulson et al. [3] reported an association between the infiltration of intratumoral CD8+ lymphocytes and improved MCC-specific survival. More recently, Dowlatshahi et al. [4] reported that a subset of tumor-associated macrophages (TAMs) in MCC expressed PD-L1, which contributes to the exhaustion of CD8+ effector T cells in the tumor microenvironment. Indeed, Afanasiev et al. [10] reported that Merkel cell polyomavirus (MCPyV)-specific CD8 T cells were detected directly ex vivo from the blood samples of patients with MCPyV-positive MCC. Interestingly, MCPyV-specific CD8 T cells and MCC-infiltrating lymphocytes expressed higher levels of therapeutically targetable PD-1 [10]. Notably, MCPyV contributes to the carcinogenesis of MCC [11]. From an immunological point of view, recent reports also suggested that the expression of B7-H molecules, including PD-L1, on TAMs and tolerogenic dendritic cells is regulated by Tregs, and that the induction of Tregs is mediated by TAMs by B7-H-related signaling [12]. In aggregate, these reports suggested the significance of crosstalk between Tregs and TAMs in the lesional skin of MCC, and these immunosuppressive cells might contribute to the exhaustion of MCC-specific CD8+ T cells to maintain an immunosuppressive tumor microenvironment. Concerning BD, we previously reported that substantial numbers of CD8+ cells were detected adjacent to tumor cells, and that the expression of PD-L1 on tumor cells diminished in parallel with the progression of BD, which might recover the exhausted CD8+ effector T cells in the tumor microenvironment of invasive BD, like MCC [4, 7]. Notably, although several cases of MCC concurrent with BD have already been reported [8, 9], to our knowledge, there is no English language report suggesting a prognostic factor for this type of tumor. In this report, we describe a case of MCC concurrent with invasive BD and compare the profiles of TILs in the lesional skin of MCC and invasive BD. Interestingly, immunohistochemical study revealed that both invasive BD and MCC contained significant numbers of CD8+ cells in the tumor lesion. Although this area contained substantial number of Foxp3+ Tregs and CD163+ TAMs, caspase 3-expressing cells were scattered in the lesional skin of BD and MCC, which might suggest induction of an anti-tumor immune response in the tumor microenvironment of MCC and BD. Our present case suggests that MCC concurrent with invasive BD might have a good prognosis because of the substantial number of CD8+ cells in the tumor. Since we did not directly assess the suppressive functions of these infiltrating cells, further analysis of the mechanisms underlying this phenomenon could offer fundamental insights into the mechanisms of our case. To confirm this hypothesis, further studies will be necessary in the future.
  12 in total

1.  Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus.

Authors:  Sumiyuki Mii; Yasuyuki Amoh; Kenichi Tanabe; Hidero Kitasato; Yuichi Sato; Kensei Katsuoka
Journal:  Eur J Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.328

2.  Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.

Authors:  Taku Fujimura; Sabine Ring; Viktor Umansky; Karsten Mahnke; Alexander H Enk
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

3.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Authors:  Kelly G Paulson; Jayasri G Iyer; Andrew R Tegeder; Renee Thibodeau; Janell Schelter; Shinichi Koba; David Schrama; William T Simonson; Bianca D Lemos; David R Byrd; David M Koelle; Denise A Galloway; J Helen Leonard; Margaret M Madeleine; Zsolt B Argenyi; Mary L Disis; Juergen C Becker; Michele A Cleary; Paul Nghiem
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

4.  Merkel cell carcinoma in situ.

Authors:  Tammie Ferringer; Hudson C Rogers; John S Metcalf
Journal:  J Cutan Pathol       Date:  2005-02       Impact factor: 1.587

5.  Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.

Authors:  Maryam M Asgari; Monica M Sokil; E Margaret Warton; Jayasri Iyer; Kelly G Paulson; Paul Nghiem
Journal:  JAMA Dermatol       Date:  2014-07       Impact factor: 10.282

6.  Clonal integration of a polyomavirus in human Merkel cell carcinoma.

Authors:  Huichen Feng; Masahiro Shuda; Yuan Chang; Patrick S Moore
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

7.  Merkel cell carcinoma concurrent with Bowen's disease: two cases, one with an unusual immunophenotype.

Authors:  Mitsuaki Ishida; Hidetoshi Okabe
Journal:  J Cutan Pathol       Date:  2013-05-15       Impact factor: 1.587

8.  Intraepidermal and dermal Merkel cell carcinoma with squamous cell carcinoma in situ: a case report with review of literature.

Authors:  Sasis Sirikanjanapong; Jonathan Melamed; Rishi R Patel
Journal:  J Cutan Pathol       Date:  2009-08-21       Impact factor: 1.587

9.  Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.

Authors:  Mitra Dowlatshahi; Victor Huang; Ahmed E Gehad; Ying Jiang; Adam Calarese; Jessica E Teague; Andrew A Dorosario; Jingwei Cheng; Paul Nghiem; Carl F Schanbacher; Manisha Thakuria; Chrysalyne D Schmults; Linda C Wang; Rachael A Clark
Journal:  J Invest Dermatol       Date:  2013-02-18       Impact factor: 8.551

10.  Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis.

Authors:  Alexandra Van Keymeulen; Guilhem Mascre; Khalil Kass Youseff; Itamar Harel; Cindy Michaux; Natalie De Geest; Caroline Szpalski; Younes Achouri; Wilhelm Bloch; Bassem A Hassan; Cédric Blanpain
Journal:  J Cell Biol       Date:  2009-09-28       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.